These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1057009)
21. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells. Grant S; Bhalla K; McCrady C Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601 [TBL] [Abstract][Full Text] [Related]
22. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine. Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044 [No Abstract] [Full Text] [Related]
23. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM; Rustum YM Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of deamination of 14C-cytosine arabinoside (NSC-63878): a useful biologic assay for tetrahydrouridine (NSC-112907). Furner RL; Mellett LB Cancer Chemother Rep; 1975; 59(4):717-20. PubMed ID: 809135 [TBL] [Abstract][Full Text] [Related]
25. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation. Durham JP; Ives DH Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509 [No Abstract] [Full Text] [Related]
26. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers. Katahira R; Ashihara H Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448 [TBL] [Abstract][Full Text] [Related]
27. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. Boothman DA; Briggle TV; Greer S Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263 [TBL] [Abstract][Full Text] [Related]
28. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [TBL] [Abstract][Full Text] [Related]
29. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine. Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884 [TBL] [Abstract][Full Text] [Related]
30. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture. Boothman DA; Briggle TV; Greer S Mol Pharmacol; 1985 May; 27(5):584-94. PubMed ID: 2581125 [TBL] [Abstract][Full Text] [Related]
31. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells. Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076 [TBL] [Abstract][Full Text] [Related]
32. Ara-C metabolism: implications for drug resistance and drug interactions. Chabner BA; Hande KR; Drake JC Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952 [TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative. Kato Y; Saito M; Fukushima H; Takeda Y; Hara T Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162 [TBL] [Abstract][Full Text] [Related]
34. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells. Riva C; Barra Y; Carcassonne Y; Cano JP; Rustum Y Chemotherapy; 1992; 38(5):358-66. PubMed ID: 1286578 [TBL] [Abstract][Full Text] [Related]
35. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808 [TBL] [Abstract][Full Text] [Related]
36. Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo. Yoshida T; Endo Y; Obata T; Kosugi Y; Sakamoto K; Sasaki T Drug Metab Dispos; 2010 Oct; 38(10):1814-9. PubMed ID: 20587622 [TBL] [Abstract][Full Text] [Related]
37. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability. Matsushita T; Ryu EK; Hong CI; MacCoss M Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of 1-beta-D-arabinofuranosylcytosine by the cell-free extract of rat ascites hepatoma, in relation to the mechanism of natural resistance. Abe I; Sato S; Watanabe M; Sato H Gan; 1978 Aug; 69(4):565-8. PubMed ID: 213338 [TBL] [Abstract][Full Text] [Related]
39. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205 [No Abstract] [Full Text] [Related]
40. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse. Ho DH Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]